Systemic infection of mice by wild-type but not Spv- Salmonella typhimurium is enhanced by neutralization of gamma interferon and tumor necrosis factor alpha

Infection and Immunity

Volumn 65, Issue 12, 1997, Pages 5191-5197

  Gulig, Paul A ^a   Doyle, Thomas J ^a   Clare Salzler, Michael J ^a   Maiese, Russell L ^a,b   Matsui, Hidenori ^a,c  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c KITASATO INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIUM COLONY; CONTROLLED STUDY; INOCULATION; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SALMONELLOSIS;

EID: 0030813821     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.12.5191-5197.1997     Document Type: Article

References (43)

1. Abrams, J. S., M.-G. Roncarolo, H. Yssel, U. Andersson, G. J. Gleich, and J. E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5-24.
2. Belardelli, F. 1995. Role of interferons and other cytokines in the regulation of the immune response. APMIS 103:161-179.
3. Benbernou, N., and C. Nauciel. 1994. Influence of mouse genotype and bacterial virulence in the generation of interferon-gamma-producing cells during the early phase of Salmonella typhimurium infection. Immunology 83:245-249.
4. Benjamin, W. H., Jr., P. Hall, S. J. Roberts, and D. E. Briles. 1990. The primary effect of the Ity locus is on the rate of growth of Salmonella typhimurium that are relatively protected from killing. J. Immunol. 144:3143-3151.
5. Buchmeier, N. A., and R. D. Schreiber. 1985. Requirement of endogenous interferon-gamma production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci. USA 82:7404-7408.
6. Cherwinski, H. M., J. H. Schumacher, K. D. Brown, and T. R. Mosmann. 1987. Two types of mouse helper T cell clone. III. Further differences in lymphokine synthesis between Th1 and Th2 clones revealed by RNA hybridization, functionally monospecific bioassays, and monoclonal antibodies. J. Exp. Med. 166:1229-1244.
7. Chesebro, B., W. Britt, L. Evans, K. Wehrly, J. Nishio, and M. Cloyd. 1983. Characterization of monoclonal antibodies reactive with murine leukemia viruses: use in analysis of strains of Friend MCF and Friend ecotropic murine leukemia virus. Virology 127:134-148.
8. Curtiss, R., III. 1981. Gene transfer, p. 243-265. In P. Gerhardt, R. G. E. Murray, R. Costilow, E. W. Nester, W. A. Wood, N. R. Krieg, and G. B. Phillips. Manual of methods for general bacteriology. American Society for Microbiology, Washington, D.C.
9. Davis, B. D. 1948. Isolation of biochemically deficient mutants of bacteria by penicillin. J. Am. Chem. Soc. 70:4267.
10. De Groote, M. A., T. Testerman, Y. Xu, G. Stauffer, and F. C. Fang. 1996. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 272:414-417.
11. s) congenic mouse strains show similar cytokine responses following infection with Salmonella dublin. J. Immunol. 156:2894-2900.
12. Fallon, M. T., W. H. Benjamin, Jr., T. R. Schoeb, and D. E. Briles. 1991. Mouse hepatitis virus strain UAB infection enhances resistance to Salmonella typhimurium in mice by inducing suppression of bacterial growth. Infect. Immun. 59:852-856.
13. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11:571-611.
14. Fierer, J., L. Eckmann, F. Fang, C. Pfeifer, B. B. Finlay, and D. Guiney. 1993. Expression of the salmonella virulence plasmid gene spvB in cultured macrophages and nonphagocytic cells. Infect. Immun. 61:5231-5236.
15. Garlington, W. A., and P. A. Gulig. 1997. Unpublished data.
16. Guiney, D. G., S. Libby, F. C. Fang, M. Krause, and J. Fierer. 1995. Growth-phase regulation of plasmid virulence genes in Salmonella. Trends Microbiol. 3:275-279.
17. Gulig, P. A., and R. Curtiss III. 1987. Plasmid-associated virulence of Salmonella typhimurium. Infect. Immun. 55:2891-2901.
18. Gulig, P. A., H. Danbara, D. G. Guiney, A. J. Lax, F. Norel, and M. Rhen. 1993. Molecular analysis of virulence genes of the salmonella virulence plasmids. Mol. Microbiol. 7:825-830.
19. Gulig, P. A., and T. J. Doyle. 1993. The Salmonella typhimurium virulence plasmid increases the growth rate of salmonellae in mice. Infect. Immun. 61:504-511.
20. 19a.Gulig, P. A., and T. J. Doyle. Unpublished data.
21. Hashimoto-Gotoh, T., F. C. H. Franklin, A. Nordheim, and K. N. Timmis. 1981. Specific-purpose plasmid cloning vectors. I. Low copy number, temperature-sensitive, mobilization-defective pSC101-derived containment vectors. Gene 16:227-235.
22. Jacobs, P., D. Radzioch, and M. M. Stevenson. 1996. In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice. Infect. Immun. 64:44-49.
23. r mice. J. Leukocyte Biol. 51:244-250.
24. Lederberg, J., and N. D. Zinder. 1948. Concentration of biochemical mutants of bacteria with penicillin. J. Am. Chem. Soc. 70:4267-4268.
25. Lennox, E. S. 1955. Transduction of linked genetic characters of the host by bacteriophage P1. Virology 1:190-206.
26. Mastroeni, P., A. Arena, G. B. Costa, M. C. Liberto, L. Bonina, and C. E. Hormaeche. 1991. Serum TNF alpha in mouse typhoid and enhancement of a Salmonella infection by anti-TNF alpha antibodies. Microb. Pathog. 11:33-38.
27. Mastroeni, P., J. N. Skepper, and C. E. Hormaeche. 1995. Effect of antitumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections. Infect. Immun. 63:3674-3682.
28. Mastroeni, P., B. Villareal, R. Demarco de Hormaeche, and C. E. Hormaeche. 1992. Serum TNFα inhibitor in mouse typhoid. Microb. Pathog. 12:343-349.
29. Mastroeni, P., B. Villarreal Ramos, and C. E. Hormaeche. 1993. Effect of late administration of anti-TNF alpha antibodies on a Salmonella infection in the mouse model. Microb. Pathog. 14:473-480.
30. Matsui, H., T. J. Doyle, and P. A. Gulig. 1995. IFN-γ and TNF-α suppress the growth of wild-type but not virulence plasmid-cured Salmonella typhimurium in orally inoculated mice, abstr. B-114, p. 185. In Abstracts of the 95th General Meeting of the American Society for Microbiology 1995. American Society for Microbiology, Washington, D.C.
31. Muotiala, A. 1992. Anti-IFN-gamma-treated mice - a model for testing safety of live Salmonella vaccines. Vaccine 10:243-246.
32. Muotiala, A., and P. H. Makela. 1990. The role of IFN-gamma in murine Salmonella typhimurium infection. Microb. Pathog. 8:135-141.
33. Muotiala, A., and P. H. Makela. 1993. Role of gamma interferon in late stages of murine salmonellosis. Infect. Immun. 61:4248-4253.
34. Nauciel, C., and F. Espinasse-Maes. 1992. Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect. Immun. 60:450-454.
35. Paul, W. E., and R. A. Seder. 1994. Lymphocyte responses and cytokines. Cell 76:241-251.
36. Pie, S., P. Matsiota-Bernard, P. Truffa-Bachi, and C. Nauciel. 1996. Gamma interferon and interleukin-10 gene expression in innately susceptible and resistant mice during the early phase of Salmonella typhimurium infection. Infect. Immun. 64:849-854.
37. Ramarathinam, L., D. W. Niesel, and G. R. Klimpel. 1993. Ity influences the production of IFN-gamma by murine splenocytes stimulated in vitro with Salmonella typhimurium. J. Immunol. 150:3965-3972.
38. Ramarathinam, L., R. A. Shaban, D. W. Niesel, and G. R. Klimpel. 1991. Interferon gamma (IFN-gamma) production by gut-associated lymphoid tissue and spleen following oral Salmonella typhimurium challenge. Microb. Pathog. 11:347-356.
39. Rhen, M., P. Riikonen, and S. Taira. 1993. Transcriptional regulation of Salmonella enterica virulence plasmid genes in cultured macrophages. Mol. Microbiol. 10:45-56.
40. Sheehan, K. C., N. H. Ruddle, and R. D. Schreiber. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J. Immunol. 142:3884-3893.
41. Tite, J. P., G. Dougan, and S. N. Chatfield. 1991. The involvement of tumor necrosis factor in immunity to Salmonella infection. J. Immunol. 147:3161-3164.
42. Tracey, K. J., and A. Cerami. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45:491-503.
43. Wilson, J. A., T. J. Doyle, and P. A. Gulig. 1997. Exponential phase expression of spvA of the Salmonella typhimurium virulence plasmid: induction in intracellular salts medium and intracellularly in mice and cultured mammalian cells. Microbiology 143:3827-3839.